Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Biostar Pharmaceuticals, Inc. (BSPM) had Normalized Pre-Tax Income of $-0.13M for the most recently reported fiscal quarter, ending 2017-09-30.
| Income Statement Financials | |
-- |
|
$-0.13M |
|
-- |
|
-- |
|
$0.57M |
|
$-0.57M |
|
$0.45M |
|
$-0.13M |
|
|
Normalized Pre-Tax Income |
$-0.13M |
$-0.13M |
|
$-0.13M |
|
$-0.13M |
|
$-0.13M |
|
$-0.57M |
|
$-0.27M |
|
2.64M |
|
2.64M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$1.00M |
|
$5.85M |
|
$40.43M |
|
$41.43M |
|
$5.28M |
|
-- |
|
-- |
|
$5.28M |
|
$36.15M |
|
$30.77M |
|
$36.15M |
|
2.64M |
|
| Cash Flow Statement Financials | |
$4.59M |
|
$-4.41M |
|
-- |
|
$0.17M |
|
$0.36M |
|
$0.19M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.19 |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$4.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-0.35% |
|
-0.41% |
|
-0.30% |
|
-0.35% |
|
$13.71 |
|
$1.74 |
|
$1.74 |
|